Effect of therapeutic anticoagulation on gas exchange in mechanically ventilated COVID-19 patients: A secondary analysis of the COVID-HEP trial
Thromb Res
.
2023 Apr:224:13-16.
doi: 10.1016/j.thromres.2023.02.003.
Epub 2023 Feb 10.
Authors
Olivier Pantet
1
,
Christophe Combescure
2
,
Zied Ltaief
1
,
Lucia Mazzolai
3
,
Séverin Jeanneret
4
,
Sara Manzocchi-Besson
5
,
Hans Stricker
6
,
Sara Cereghetti
7
,
Jérôme Pugin
7
,
Alexandra Calmy
8
,
Christophe Marti
9
,
Helia Robert-Ebadi
10
,
Pierre Fontana
10
,
Marc Righini
10
,
Alessandro Casini
10
,
Marc Blondon
11
Affiliations
1
Division of Intensive Care, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
2
Clinical Research Center, Geneva University Hospitals, Geneva, Switzerland.
3
Division of Angiology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
4
Division of Intensive Care, Hôpital du Valais, Sion, Switzerland.
5
Unit of Angiology, Hôpital du Valais, Sion, Switzerland.
6
Division of Angiology, Locarno Regional Hospital, Locarno, Switzerland.
7
Division of Intensive Care, Geneva University Hospitals, Geneva, Switzerland.
8
HIV/AIDS Unit, Division of Infectious Disease, Geneva University Hospitals, Geneva, Switzerland.
9
Division of General Internal Medicine, Geneva University Hospitals, Geneva, Switzerland.
10
Division of Angiology and Hemostasis, Geneva University Hospitals, Geneva, Switzerland.
11
Division of Angiology and Hemostasis, Geneva University Hospitals, Geneva, Switzerland. Electronic address:
[email protected]
.
PMID:
36801649
PMCID:
PMC9911973
DOI:
10.1016/j.thromres.2023.02.003
No abstract available
Keywords:
Anticoagulation; COVID-19; Gas exchange; Heparin; Mechanical ventilation; SARS-CoV2.
Publication types
Letter
MeSH terms
Anticoagulants / pharmacology
Anticoagulants / therapeutic use
Blood Coagulation
COVID-19*
Humans
Respiration, Artificial
Substances
Anticoagulants